74 completed, 18 unknown, 7 recruiting, 4 not yet recruiting. 40 Phase 3, 16 Phase 4, 15 Not applicable, 14 Phase 2, 5 Phase 1.
Follow Parotid Diseases: new trials by email Literature Review of Parotid Diseases trials Research Report on Parotid Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age MMRVNS vaccine, MMRV vaccine, DTaP-IPV vaccine - Measles, Mumps | Phase 3 | Not yet recruiting | GlaxoSmithKline | 1860 | 2026-08-11 | 2026-08-03 |
| Clinical Tolerance of an Intraparotid Injection of Bupivacaine, Combined With Dexamethasone, After Parotidectomy for Benign Tumor Intraparotid injection of bupivacaine/ dexamethasone - Parotid Neoplasm, Bupivacaine | Early Phase 1 | Recruiting | Centre Hospitalier Universitaire de Nīmes | 10 | 2026-05-18 | 2026-09-10 |
| A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age MMRVNS, MMRV - Measles, Measles-Mumps-Rubella+Chickenpox Vaccine | Phase 3 | Recruiting | GlaxoSmithKline | 1209 | 2026-05-11 | 2026-07-08 |
| Swedish National Parotidectomy Study (SNaPs): Drainless Versus Standard Surgery Active wound drainage (Standard of Care), Omission of active wound drain - Parotid Neoplasms, Post-operative Complications | Not applicable | Recruiting | Uppsala University Hospital | 600 | 2026-05-06 | 2026-06-04 |
| Facial Nerve Monitoring During Parotid and Facial Surgery Using a Non-Invasive Patch Non-invasive facial nerve monitoring patch - Parotid Gland Tumor, Facial and Neck Rhytides | Not applicable | Not yet recruiting | Sheba Medical Center | 20 | 2026-05-01 | 2026-04-13 |
| the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines Polio, Measles | Not yet recruiting | China National Biotec Group Company Limited | 600 | 2026-01-30 | 2026-01-14 | |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients Commercial measles, mumps, and rubella (MMR) vaccine - Heart Transplant Infection Prevention | Phase 4 | Recruiting | Children's Mercy Hospital Kansas City | 60 | 2025-09-11 | 2026-09-24 |
| A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults CVM150, CVM26, Placebo - Mumps | Phase 1 | Active not recruiting | CyanVac LLC | 60 | 2025-05-14 | 2025-12-11 |
| Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid Carcinoma Proton Beam Therapy - Parotid Cancer | Not applicable | Not yet recruiting | The Christie NHS Foundation Trust | 97 | 2024-11-01 | 2024-08-21 |
| Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months SIBP MMR Vaccine, GSK MMR Vaccine (PRIORIX), Yellow Fever Vaccine (Stamaril) - Measles-Mumps-Rubella | Phase 3 | Completed | Shanghai Institute Of Biological Products | 1200 | 2024-06-28 | 2026-01-08 |
| Function-Preserving Surgery for Parotid Tumors: Intracapsular Versus Superficial Parotidectomy; A Randomized Clinical Trial. Superficial parotidectomy, Intracapsular parotidectomy (ICP) - Parotid Tumors, Parotidectomy | Not applicable | Completed | Al-Azhar University | 120 | 2024-05-01 | 2025-09-22 |
| Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) Vero cell-drived inactive Japanese encephalitis vaccine, Measles-Mumps-Rubella Vaccine - Japanese Encephalitis, Measles | Phase 4 | Completed | Liaoning Chengda Biotechnology CO., LTD | 408 | 2024-03-02 | 2025-08-28 |
| Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination MMR booster vaccination (as M-M-R-VaxPro) - Mumps, Measles | Phase 3 | Unknown | University of Zurich | 200 | 2023-12-01 | 2024-01-08 |
| The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students Mumps vaccine, Live (MV), Influenza Vaccine, inactivated, quadrivlent(QIV) - Mumps, Influenza | Phase 4 | Unknown | Sinovac Biotech Co., Ltd | 400 | 2023-11-04 | 2024-01-17 |
| Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine, Inactivated SARS-CoV-2 vaccine coadministered with MMR, Inactivated SARS-CoV-2 vaccine administered alone - SARS-CoV-2 Infection, Varicella | Phase 4 | Unknown | Shanghai Municipal Center for Disease Control and Prevention | 540 | 2023-08-01 | 2023-07-19 |
| A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age Investigational MMRV(H)NS vaccine, Investigational MM(H)RVNS vaccine, Investigational M(L)M(L)R(L)V(L)NS vaccine - Measles; Mumps; Rubella; Chickenpox, Measles | Phase 2 | Completed | GlaxoSmithKline | 801 | 2022-12-14 | 2025-06-22 |
| Role of Methylene Blue in Parotid Surgery Methylene blue dye - Parotid Tumor | Not applicable | Unknown | Assiut University | 20 | 2022-06-01 | 2022-06-02 |
| Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation Magnetic Resonance Imaging on 3T scanner (Magnetom Prisma, SIemens) with dedicated neurogram sequences (Constructive interference in steady state - CISS; Dual Echo Steady State - DESS) - Parotid Neoplasms | Not applicable | Recruiting | Chinese University of Hong Kong | 50 | 2022-02-01 | 2026-04-03 |
| MRI and Fine Needle Aspiration in the Diagnosis of Parotid Tumors Parotid Tumor | Completed | University Hospital, Strasbourg, France | 133 | 2021-11-15 | 2021-12-10 |
Showing 20 of 111. Sign in to see all of them.
Mumps (81) · Measles (71) · Rubella (69) · Chickenpox (44) · Parotid Neoplasms (27) · Haemophilus Infections (5) · Encephalitis, Japanese (4) · Hepatitis A (4) · Tetanus (4) · Thyroid Neoplasms (4) · Facial Paralysis (3) · Head and Neck Neoplasms (3) · Meningitis, Meningococcal (3) · Poliomyelitis (3) · Whooping Cough (3)
Mouth Diseases (111) · Salivary Gland Diseases (111) · Stomatognathic Diseases (111) · Infections (82) · Virus Diseases (82) · Mononegavirales Infections (81) · Paramyxoviridae Infections (81) · Parotitis (81) · RNA Virus Infections (81) · Rubulavirus Infections (81) · Morbillivirus Infections (71) · Rubivirus Infections (69) · Togaviridae Infections (69) · DNA Virus Infections (47)
measles, mumps, rubella, varicella vaccine (22) · Measles-Mumps-Rubella Vaccine (16) · Chickenpox Vaccine (9) · Hepatitis A Vaccines (7) · Rubella Vaccine (5) · Heptavalent Pneumococcal Conjugate Vaccine (4) · 13-valent pneumococcal vaccine (3) · Meningococcal Vaccines (3) · Mumps Vaccine (3) · Vaccines (3) · Vaccines, Attenuated (3) · CRM197 (non-toxic variant of diphtheria toxin) (2) · DTPP vaccine (2) · Long-Term Synaptic Depression (2) · Priorix-Tetra vaccine (2)
GlaxoSmithKline (24) · Merck Sharp & Dohme LLC (19) · Sanofi Pasteur, a Sanofi Company (5) · Institute of Medical Biology, Chinese Academy of Medical Sciences (3) · Sinovac (Dalian) Vaccine Technology Co., Ltd. (3) · The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (3) · Fondation Ophtalmologique Adolphe de Rothschild (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Al-Azhar University (1) · Alume Biosciences, Inc. (1) · Assaf-Harofeh Medical Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Assiut University (1) · British Columbia Cancer Agency (1) · CHU de Reims (1)
United States (28) · China (15) · France (9) · Italy (9) · Germany (8) · Puerto Rico (7) · Taiwan (7) · Finland (5) · Egypt (4) · Brazil (3) · Estonia (3) · South Korea (3) · Canada (2) · Israel (2) · Netherlands (2)
Jingchen Ma (2) · Weijun Hu, Master (2) · Amanda Dempsey, MD, PhD, MPH (1) · Anna Lee (1) · Anne Fiquet, MD (1) · Beifang Yang, PhD (1) · Benjamin Lallemant (1) · Carl T. D'Angio, MD (1) · Chiu Wing WInnie Chu, MD, FHKCR (1) · Chris Nutting (1)
PMID 12533152, PMID 16094218, PMID 16452343, PMID 16567978, PMID 16804432, PMID 17332177, PMID 17502347, PMID 19305145, PMID 19366435, PMID 20955461, PMID 22123890, PMID 22406278, PMID 22772170, PMID 24614759, PMID 25765966, PMID 26362659, PMID 27149048, PMID 27423382, PMID 28481690, PMID 29149611, PMID 29478347, PMID 29902133, PMID 30481110, PMID 30943124, PMID 31481612, PMID 31682550, PMID 31980466, PMID 32359091, PMID 32919526, PMID 33836153, PMID 34990208, PMID 35114169, PMID 35361487, PMID 35588692, PMID 35680043, PMID 35777186, PMID 35835611, PMID 36653029, PMID 36748723, PMID 37733724, PMID 39979665, PMID 40121391, PMID 40595556, PMID 41276263, PMID 41920388
2025 (4), 2014 (1), 2015 (1)